Researchers have used explainable AI to uncover factors that influence inpatients’ opinions when they’re completing satisfaction surveys following hospitalization.

AI company Exscientia has received a vote of confidence approaching $1.2 billion in value from Bristol-Myers Squibb.

Google Health is launching a free app that uses AI trained on more than 16,000 clinical dermatology cases and can identify hundreds of skin conditions, including cancers, with accuracy comparable to that of board-certified dermatologists in the U.S.

A medical AI startup focused on breast cancer diagnostics has uncloaked from stealth mode, appointing an MD as CEO and concertedly promoting its initial software offering seven months after the FDA approved the product.

Walmart is advancing its healthcare capabilities with the acquisition of telehealth provider MeMD.

The FDA has approved an AI tool for speeding thyroid sonography workflows while, across the Atlantic, the European Union has OK’d an AI-based ultrasound device that guides nerve blocking as a form of local anesthesia

The last two weeks saw market clearances granted in Europe for AI-based software focused on remote patient monitoring, prostate oncology and real-time guidance of coronary stenting.

The FDA has granted 510(k) clearance to a French startup for surgery software that combines AI with augmented reality and computer vision.